Evidence map›Paper›PMID 22269944›Full record

ArticleJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society2012

Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study.

Kristin M Galetta, Jennifer Graves, Lauren S Talman, Deacon J Lile, Elliot M Frohman, Peter A Calabresi, Steven L Galetta, Laura J Balcer

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kristin M GalettaDepartment of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Jennifer Graves
Lauren S Talman
Deacon J Lile
Elliot M Frohman
Peter A Calabresi
Steven L Galetta
Laura J Balcer
University of Pennsylvania · US

Funding

Novel Clinical and Ocular Imaging Outcomes with Long-Term Follow-Up in MSR01EY019473 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BALCER, LAURA · 2009 to 2010
$1.3M
Longitudinal Assessment of Visual Function in MSR01EY014993 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BALCER, LAURA · 2003 to 2007
$891k
Novel visual outcome measures in optic neuritis and multiple sclerosisK24EY018136 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BALCER, LAURA · 2007 to 2011
$792k
CSR NIH HHS RG 4212-A-4NEI NIH HHS K24 EY 018136NEI NIH HHS K24 EY018136NEI NIH HHS R01 EY 014993NEI NIH HHS R01 EY014993NEI NIH HHS R01 EY019473
6 · The paper itself

Abstract

backgroundBenign multiple sclerosis (MS), traditionally defined as Expanded Disability Status Scale (EDSS) score ≤3 and ≥15-year disease duration, is thought to follow a milder clinical course. We determined the extent of visual pathway axonal loss by optical coherence tomography (OCT) retinal nerve fiber layer (RNFL) thickness in a benign MS cohort and examined the relation to vision and quality of life (QOL).

methodsIn this longitudinal study of vision in MS at 3 academic centers, a subset of patients with EDSS, visual function, OCT, and QOL assessments was analyzed. Low- and high-contrast letter acuity was performed to assess visual function. RNFL thickness was determined using time-domain OCT. QOL scales included the 25-Item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) and Short Form-36 Health Survey.

resultsAmong 68 patients (135 eyes) studied longitudinally, 13 (26 eyes) had benign MS using criteria of EDSS score ≤3 and ≥15-year disease duration. Benign MS eyes had as much RNFL thinning (-3.6 μm, P = 0.0008 vs baseline, paired t test) as typical MS eyes (-3.3 μm, P < 0.0001). Both groups had significant low-contrast acuity loss. History of optic neuritis (ON) was more frequent in benign MS (69% vs 33% of eyes). History of ON distinguished benign vs typical MS (P = 0.002) and correlated with RNFL thickness at baseline (P = 0.002) and disease duration (P = 0.03) but not EDSS (P = 0.32, logistic regression). NEI-VFQ-25 scores were also worse for benign MS, accounting for age (75 ± 21 vs 88 ± 11, P = 0.005).

conclusionPatients with benign MS have RNFL axonal loss that is as marked as that of typical MS and have reduced vision and QOL. While overall neurologic impairment is mild, visual dysfunction, not well captured by the EDSS, accounts for a substantial degree of disability in benign MS.

Indexed as

FemaleFollow-Up StudiesHumansMaleMiddle AgedMultiple SclerosisProspective StudiesQuality of LifeRetinal Ganglion CellsSurveys and QuestionnairesTomography, Optical CoherenceVisual AcuityVisual Pathways

Identifiers

PMID22269944
PMCPMC3427935
OpenAlexW1988875090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.